CLINICAL VARIATION OF AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY (APECED) IN A SERIES OF 68 PATIENTS

被引:724
|
作者
AHONEN, P [1 ]
MYLLARNIEMI, S [1 ]
SIPILA, I [1 ]
PERHEENTUPA, J [1 ]
机构
[1] UNIV HELSINKI,CHILDRENS HOSP,SF-00290 HELSINKI 29,FINLAND
关键词
D O I
10.1056/NEJM199006283222601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To define the clinical picture and course of the autosomal recessive disease called autoimmune polyendocrinopathy—candidiasis—ectodermal dystrophy (APECED), we report data from our 10-month to 31-year follow-up of 68 patients from 54 families, now 10 months to 53 years of age. The clinical manifestations varied greatly and included from one to eight disease components, 63 percent of the patients having three to five of them. The initial manifestation was oral candidiasis in 41 patients (60 percent), intestinal malabsorption in 6 (9 percent), and keratopathy in 2 (3 percent). All the patients had candidiasis at some time. The earliest endocrine component appeared at 19 months to 35 years of age. Hypoparathyroidism was present in 54 patients (79 percent), adrenocortical failure in 49 (72 percent), and gonadal failure in 15 (60 percent) of the female patients ≥ years of age and 4 (14 percent) of the male patients ≥16 years of age. There were multiple endocrine deficiencies in half the patients. From 4 to 29 percent of the patients had periodic malabsorption, gastric parietal-cell atrophy, hepatitis, alopecia, vitiligo, or a combination of these conditions. Dental-enamel hypoplasia and keratopathy were also frequent but were not attributable to hypoparathyroidism. In the patients whose initial manifestation (other than candidiasis) was adrenal failure, the other components developed less often than in the remaining patients. We conclude that the clinical spectrum in patients with APECED is broad. The majority of patients have three to five manifestations, some of which may not appear until the fifth decade. Therefore, all patients need lifelong follow-up for the detection of new components of the disease. AUTOIMMUNE polyendocrinopathy—candidiasis—ectodermal dystrophy (APECED) is an autosomal recessive disease characterized by a variable combination of (1) failure of the parathyroid glands, adrenal cortex, gonads, pancreatic beta cells, gastric parietal cells, and thyroid gland, and hepatitis; (2) chronic mucocutaneous candidiasis; and (3) dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopathy.1 2 3 4 5 This disease has many names, one being autoimmune polyglandular disease Type I.4 We prefer the name APECED, because it emphasizes the three groups of disease components.2,3 There are numerous reports describing single patients or a few patients with APECED. These have been reviewed extensively,4 5 6 7 8 9 10 but the reviews have given… © 1990, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1829 / 1836
页数:8
相关论文
共 50 条
  • [42] Immunological findings in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and their family members:: Are heterozygotes subclinically affected?
    Sedivá, A
    Ciháková, D
    Lebl, J
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 (09) : 1491 - 1496
  • [43] Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives
    Cervato, Sara
    Mariniello, Barbara
    Lazzarotto, Francesca
    Morlin, Luca
    Zanchetta, Renato
    Radetti, Giorgio
    De Luca, Filippo
    Valenzise, Mariella
    Giordano, Roberta
    Rizzo, Daniela
    Giordano, Carla
    Betterle, Corrado
    CLINICAL ENDOCRINOLOGY, 2009, 70 (03) : 421 - 428
  • [44] CYTOPLASMIC ISLET CELL ANTIBODIES IN PATIENTS WITH AUTOIMMUNE POLYENDOCRINOPATHY CANDIDOSIS ECTODERMAL DYSTROPHY (APECED)
    AHONEN, P
    MIETTINEN, A
    PERHEENTUPA, J
    ACTA ENDOCRINOLOGICA, 1985, 109 : 78 - 78
  • [45] Specific Functional Gammopathy Underlying Infectious Susceptibility in a Patient with Autoimmune-Polyendocrinopathy-Candidiasis- Ectodermal Dystrophy (APECED)
    Constantine, Gregory M.
    Ferre, Elise
    Lionakis, Michail
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S111 - S112
  • [46] Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
    Siikala, Emilia
    Rautemaa, Riina
    Richardson, Malcolm
    Saxen, Harri
    Bowyer, Paul
    Sanglard, Dominique
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2505 - 2513
  • [47] CD4+CD25+T regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED)
    Ryan, KR
    Lawson, C
    Arkwright, P
    Isaacs, J
    Lilic, D
    IMMUNOLOGY, 2005, 116 : 70 - 71
  • [48] Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis
    Ach, Taieb
    Hadami, Ben Yamna
    Ghariani, Nadia
    Said ElMabrouk, Randa
    Ben Abdelkrim, Asma
    Kacem, Maha
    Denguezli, Mohamed
    Ach, Koussay
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2023, 2023 (02)
  • [49] A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED)
    Fierabracci, Alessandra
    Bizzarri, Carla
    Palma, Alessia
    Milillo, Annamaria
    Bellacchio, Emanuele
    Cappa, Marco
    GENE, 2012, 511 (01) : 113 - 117
  • [50] The Boston Keratoprosthesis in 2 Patients With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
    Yildiz, Elvin H.
    Saad, Christine G.
    Eagle, Ralph
    Ayres, Brandon D.
    Cohen, Elisabeth J.
    CORNEA, 2010, 29 (03) : 354 - 356